Toxicity, Time, and the Patient Experience in Blood Cancers

Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs

Clinical Advances in Myeloma: A Nordic Perspective

Grand Rounds in Leukemia: MD Anderson Fellows on AML Endpoints

Editor’s Special Episode: Progress and Prospects in CLL Management

Today’s Clinical Trials Define the Next Era in Myeloma

‘The HemOnc Pulse Live:’ Transforming ALL Treatment Pathways

Evolving Approaches in the Management of MDS

‘The HemOnc Pulse Live!’: AML in Transition

From Trials to Practice: What's New and What's Next for Myeloma

Editor’s Special Episode: Innovations in B-NHL

Editor’s Special Episode: Treating CLL Now and in the Future

'The HemOnc Pulse Live': Controversies in Frontline Myeloma

Editor’s Special Episode: ASCO 2025 Highlights in AML with Dr. Amir Fathi

Navigating Drug Accessibility in Cancer Care

The 'HemOnc Pulse Live' Controversies in Aggressive NHL

Inside the War on Myeloid Malignancies: Early Clues & Bold Innovations

'The HemOnc Pulse' Live 2025: Controversies in MDS

Redirected Strategy: Tal and TEC in the Myeloma Mix

Dr. Usmani Highlights Myeloma Presentations from SOHO 2024